Neutrophilic Inflammation: Molecular Mechanisms and Drug Discovery
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 5354
Special Issue Editors
Interests: inflammation pharmacology; drug discovery; cancer biology
Special Issues, Collections and Topics in MDPI journals
Interests: natural products chemistry; mass spectrometry-based metabolomics; pharmacognosy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue "Neutrophilic Inflammation: Molecular Mechanisms and Drug Discovery" aims to provide a comprehensive overview of the molecular mechanisms underlying neutrophilic inflammation, as well as the current state of drug discovery efforts targeting this process. Neutrophilic inflammation plays a critical role in the pathogenesis of various diseases, including acute respiratory distress syndrome, chronic obstructive pulmonary disease sepsis, rheumatoid arthritis, psoriasis, systemic lupus erythematosus, and cancer. The Special Issue will cover a broad range of topics, including neutrophil recruitment and activation, signaling pathways, the role of neutrophils in tissue damage and repair, and the development of novel therapeutic strategies. The ultimate goal is to promote a better understanding of the complex biology of neutrophilic inflammation and to facilitate the identification of new drug targets for treating inflammatory diseases. The Issue welcomes original research articles, reviews, and perspectives that cover any aspect of neutrophilic inflammation and drug discovery.
Dr. Po-Jen Chen
Dr. Kuei-Hung Lai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neutrophilic inflammation
- molecular mechanisms
- drug discovery
- neutrophil activation
- signaling pathways
- therapeutic strategies
- inflammatory and autoimmune diseases
- drug targets
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.